Live Quote · OTCACMSYHealthcare · Medical - Diagnostics & Research

AccuStem Sciences Limited

$0.13▼ 7.14%($-0.01)

MKT CAP $0

50%

Bullish

50%

Bullish

TickerSpark Score

34/100

▌ Poor

20

Valuation

60

Profitability

40

Growth

20

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACMSY research report →

Price Chart

-18.75% · this period

52-Week Range22% of range

Low

$0.01

Current

$0.13

High

$0.56

Insider ActivityLast quarter

6 Buys0 Sells

Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

Date	Insider	Role	Type	Shares	Value
Jun 13, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	400	$440
Jun 13, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	2,000	$2.00K
Jun 12, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	8,991	$7.46K
Jun 11, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	28,205	$11.00K
Apr 9, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	3,000	$2.01K
Apr 8, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	35,000	$23.27K
Apr 7, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	35,000	$22.75K
Apr 7, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	17,802	$10.84K
Mar 18, 25	CERRONE GABRIELE M	director, 10 percent owner:	buy	100,000	$44.70K
Dec 31, 24	CERRONE GABRIELE M	director, 10 percent owner:	buy	100,000	$38.10K

A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.

AccuStem Sciences Limited

Price Chart

About the company

Get TickerSpark's AI analysis on ACMSY

Recent insider transactions

Our ACMSY coverage

No research on ACMSY yet